Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)
Close on Nov 18, 2026Market cap $24.59MP/E –Yield –
Rockwell Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Rockwell Medical's revenue for the twelve months ending Jun 30, 2026 was $69.39M, down 21.1% year over year. For fiscal 2025 it was $69.26M, down 31.8% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $101.49M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.26M | -31.8% |
| FY2024 | Dec 31, 2024 | $101.49M | +21.4% |
| FY2023 | Dec 31, 2023 | $83.61M | +14.8% |
| FY2022 | Dec 31, 2022 | $72.81M | +17.6% |
| FY2021 | Dec 31, 2021 | $61.93M | -0.4% |
| FY2020 | Dec 31, 2020 | $62.20M | +1.5% |
| FY2019 | Dec 31, 2019 | $61.30M | -3.3% |
| FY2018 | Dec 31, 2018 | $63.39M | +10.6% |
| FY2017 | Dec 31, 2017 | $57.30M | +7.5% |
| FY2016 | Dec 31, 2016 | $53.28M | -3.7% |
| FY2015 | Dec 31, 2015 | $55.35M | +2.1% |
| FY2014 | Dec 31, 2014 | $54.19M | +3.5% |
| FY2013 | Dec 31, 2013 | $52.38M | +5.1% |
| FY2012 | Dec 31, 2012 | $49.84M | +1.8% |
| FY2011 | Dec 31, 2011 | $48.97M | -17.8% |
| FY2010 | Dec 31, 2010 | $59.55M | +8.8% |
| FY2009 | Dec 31, 2009 | $54.73M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.78M | +10.6% |
| Q1 FY2026 | Mar 31, 2026 | $17.34M | -8.3% |
| Q4 FY2025 | Dec 31, 2025 | $18.35M | -25.6% |
| Q3 FY2025 | Sep 30, 2025 | $15.93M | -43.8% |
| Q2 FY2025 | Jun 30, 2025 | $16.07M | -37.8% |
| Q1 FY2025 | Mar 31, 2025 | $18.91M | -16.6% |
| Q4 FY2024 | Dec 31, 2024 | $24.67M | +11.6% |
| Q3 FY2024 | Sep 30, 2024 | $28.32M | +19.1% |
| Q2 FY2024 | Jun 30, 2024 | $25.83M | +42.9% |
| Q1 FY2024 | Mar 31, 2024 | $22.68M | +15.3% |
| Q4 FY2023 | Dec 31, 2023 | $22.09M | +14.4% |
| Q3 FY2023 | Sep 30, 2023 | $23.77M | +27.2% |
| Q2 FY2023 | Jun 30, 2023 | $18.08M | -3.2% |
| Q1 FY2023 | Mar 31, 2023 | $19.67M | +22.0% |
| Q4 FY2022 | Dec 31, 2022 | $19.31M | +26.0% |
| Q3 FY2022 | Sep 30, 2022 | $18.69M | +16.9% |
| Q2 FY2022 | Jun 30, 2022 | $18.68M | +23.4% |
| Q1 FY2022 | Mar 31, 2022 | $16.12M | +4.2% |
| Q4 FY2021 | Dec 31, 2021 | $15.33M | +1.1% |
| Q3 FY2021 | Sep 30, 2021 | $15.99M | +4.6% |
| Q2 FY2021 | Jun 30, 2021 | $15.14M | -4.8% |
| Q1 FY2021 | Mar 31, 2021 | $15.47M | -2.4% |
| Q4 FY2020 | Dec 31, 2020 | $15.16M | -2.1% |
| Q3 FY2020 | Sep 30, 2020 | $15.28M | -0.8% |
| Q2 FY2020 | Jun 30, 2020 | $15.90M | +7.1% |
| Q1 FY2020 | Mar 31, 2020 | $15.86M | +1.9% |
| Q4 FY2019 | Dec 31, 2019 | $15.49M | -8.1% |
| Q3 FY2019 | Sep 30, 2019 | $15.41M | -7.6% |
| Q2 FY2019 | Jun 30, 2019 | $14.85M | -0.5% |
| Q1 FY2019 | Mar 31, 2019 | $15.56M | +4.1% |
| Q4 FY2018 | Dec 31, 2018 | $16.85M | +13.6% |
| Q3 FY2018 | Sep 30, 2018 | $16.67M | +14.0% |
| Q2 FY2018 | Jun 30, 2018 | $14.91M | +12.6% |
| Q1 FY2018 | Mar 31, 2018 | $14.95M | +2.4% |
| Q4 FY2017 | Dec 31, 2017 | $14.84M | +10.8% |
| Q3 FY2017 | Sep 30, 2017 | $14.63M | +14.1% |
| Q2 FY2017 | Jun 30, 2017 | $13.24M | – |
| Q1 FY2017 | Mar 31, 2017 | $14.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.39M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.81M | – |
See a number that looks wrong?